Of the World Health Organization's top 10 global health threats of 2019, six were infectious diseases. Do you think those threats were eliminated or reduced by the end of 2019?
In your opinion, what is the most important risk associated with 5-aminosalicylate therapy in patients with inflammatory bowel disease? Let us know by taking the poll!